Repurposing avermectins as new potential TB therapies
نویسندگان
چکیده
منابع مشابه
Biocomputing drug repurposing toward targeted therapies
inhibition of the oncogenic activation of signalling pathways represents the main goal of drug discovery in oncology. Selective inhibitors of oncogenes such as mutated kinases and phosphatases have been identified mainly through traditional small molecule drug screenings aimed at identifying inhibitors of catalytic activity. However, ever-increasing failure rates, high costs, unsatisfactory saf...
متن کاملRadical Host-Specific Therapies for TB
Although proinflammatory cytokines such as TNF are critical for containment of tuberculosis, they can also exacerbate disease when produced at high levels. In this issue of Cell, Roca and Ramakrishnan demonstrate that high TNF production induces reactive oxygen species in infected macrophages, ultimately leading to macrophage necrosis and bacterial dissemination.
متن کاملω3 Polyunsaturated Fatty Acids as Immunomodulators in Colorectal Cancer: New Potential Role in Adjuvant Therapies
Diet composition may affect the onset and progression of chronic degenerative diseases, including cancer, whose pathogenesis relies on inflammatory processes. Growing evidence indicates that diet and its components critically contribute to human health, affecting the immune system, secretion of adipokines, and metabolic pathways. Colorectal cancer (CRC) is one of the leading causes of death wor...
متن کاملCannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
OBJECTIVES The endocannabinoid system is an endogenous lipid signalling network comprising arachidonic-acid-derived ligands, cannabinoid (CB) receptors, transporters and endocannabinoid degrading enzymes. The CB(1) receptor is predominantly expressed in neurons but is also co-expressed with the CB(2) receptor in peripheral tissues. In recent years, CB receptor ligands, including Delta(9)-tetrah...
متن کاملRepurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer
Albendazole is an anti-helminthic drug that has been shown to exhibit anti-cancer properties, however its activity in head and neck squamous cell cancer (HNSCC) was unknown. Using a series of in vitro assays, we assessed the ability of albendazole to inhibit proliferation in 20 HNSCC cell lines across a range of albendazole doses (1 nM-10 μM). Cell lines that responded to treatment were further...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Infectious Diseases
سال: 2014
ISSN: 1201-9712
DOI: 10.1016/j.ijid.2014.03.841